One such mechanism in glioma may be through methylation-induced disruption of a CCCTC-binding factor (CTCF) binding site, resulting in aberrant activation of platelet-derived growth factor receptor alpha (PDGRFA) [63]. Here, PDGFRA is linked to central nervous system cancer.